Akio Higuchi

Akio Higuchi

Auto-generated profile, based on publicly available information

Akio Higuchi

Department of Radiology, Chiba University Hospital, Chiba, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2016 in Oncology Letters
Verified
Journal Article
Open access
PDF file
AHAkio Higuchi
Akio Higuchi
TOTakashi Oshima
Takashi Oshima
KYKazue Yoshihara
Kazue Yoshihara
KSKentaro Sakamaki
Kentaro Sakamaki
TAToru Aoyama
Toru Aoyama
MMMunetaka Masuda
Munetaka Masuda
Overall survival remains unsatisfactory in stage II/III gastric cancer, even after curative surgery and adjuvant chemotherapy. Platelet-derived growth factor receptor-β (PDGFR-β) is associated with the proliferation of cancer cells. The present study therefore investigated the association of PDGFR-β gene expression with patient outcome in 134 stage II/III gastric cancer patients who received adjuvant chemotherapy with S-1. Relative PDGFR-β gene expression was measured in surgical cancer tissue and adjacent normal mucosa specimens by reverse transcription-quantitative polymerase chain reaction. The PDGFR-β gene expression levels were found to be significantly higher in the cancer tissues compared with the adjacent normal mucosa. A high level of PDGFR-β gene expression was associated with a significantly poorer 5-year overall survival rate compared with a low level of PDGFR-β expression. Upon multivariate analysis, PDGFR-β gene expression was found to be an independent predictor of survival. Overall, the study indicates that PDGFR-β overexpression in gastric cancer tissues is a useful independent predictor of outcome in patients with stage II/III gastric cancer who receive adjuvant chemotherapy with S-1.

16 December 2021 in Radiology Case Reports
Verified
Journal Article
Open access
HYHajime Yokota
Hajime Yokota
HMHiroki Mukai
Hiroki Mukai
SHShinya Hattori
Shinya Hattori
KOKenji Ohira
Kenji Ohira
AHAkio Higuchi
Akio Higuchi
TUTakashi Uno
Takashi Uno
Since leptomeningeal carcinomatosis is rarely observed before diagnosis of the primary cancer, its detection is often delayed. We report the case of a 60-year-old woman who presented with lung adenocarcinoma with leptomeningeal carcinomatosis. Magnetic resonance imaging showed the characteristic abnormal hyperintensity along the ventral surface of the brain stem on fluid-attenuated inversion recovery and diffusion weighted imaging. It had no contrast uptake. Based on these findings, we were able to make an early diagnosis of leptomeningeal carcinomatosis of lung adenocarcinoma. This condition was resolved after treatment with a tyrosine kinase inhibitor.

5 May 2021 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
MNMasakatsu Numata
Masakatsu Numata
HTHiroshi Tamagawa
Hiroshi Tamagawa
KKKeisuke Kazama
Keisuke Kazama
YAYosuke Atsumi
Yosuke Atsumi
KIKenta Iguchi
Kenta Iguchi
YRYasushi Rino
Yasushi Rino
Aim: To compare the mid-term oncological results between patients with low rectal cancer who underwent minimally invasive laparoscopic surgery (MILS) and those who underwent open surgery (OS). Patients and Methods: Overall, 262 matched patients who underwent primary resection for low rectal cancer between 2000 and 2019 were divided into MILS (n=131; n=107, conventional laparoscopic surgery; n=24, robotic surgery) and OS (n=131) groups. The short- and mid-term outcomes were compared. Results: Similar baseline characteristics were noted. The operative time was longer and blood loss was lesser in the MILS group; the conversion rate was 3.8%. The incidence of postoperative complications was similar. The 2-year cumulative incidence of local recurrence was noted to be much lower in the MILS group (1.9%) than in the OS group (8.4%). MILS had a significantly low hazard ratio (0.208, p=0.036). Conclusion: MILS has potential benefits in reducing local recurrence of low rectal cancer.

1 January 2013 in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Verified
Journal Article
Open access
PDF file
SHSatoshi Hasegawa
Satoshi Hasegawa
NSNatsuko Sugimasa
Natsuko Sugimasa
KSKimihisa Shino
Kimihisa Shino
AHAkio Higuchi
Akio Higuchi
TNTakashi Nakayama
Takashi Nakayama
HIHideyuki Ike
Hideyuki Ike
乳癌の消化管転移は比較的まれとされている.術後17年目に直腸に転移した浸潤性小葉癌に対してホルモン療法が奏効した1例を経験したので文献的考察を加え報告する.症例は67歳,女性.1993年9月左乳癌のため胸筋温存乳房切除術を施行された.術後病理診断はT2N1M0 Stage IIB,浸潤性乳管癌,硬癌,ly:+,v:+,リンパ節転移(3/9)であった.2010年11月便秘が出現し近医を受診し直腸狭窄が疑われ当院紹介受診となった.注腸検査では下部直腸に全周性の狭窄を認めていた.大腸内視鏡では狭窄部位の粘膜は悪性所見がなかったため,粘膜下の針生検を行った.平滑筋束間にびまん性に浸潤する小型細胞を認め,免疫染色の結果から乳癌由来で浸潤性小葉癌と診断された.2010年12月よりレトロゾールを開始したところ,直腸狭窄は改善した.治療開始2年現在,人工肛門を造設することなく外来通院中である.

1 January 2011 in Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
Verified
Journal Article
Open access
PDF file
KYKouichiro Yamaoku
Kouichiro Yamaoku
HSHiroyuki Saeki
Hiroyuki Saeki
YKYusuke Katayama
Yusuke Katayama
NSNobuyasu Suganuma
Nobuyasu Suganuma
AHAkio Higuchi
Akio Higuchi
MMMunetaka Masuda
Munetaka Masuda
症例は82歳,男性.体重減少を主訴に近医を受診し,横行結腸癌の診断を受け,平成21年8月に当科を紹介受診した.術前精査で腸間膜静脈硬化症の所見を認めた. 平成21年9月に右半結腸切除術を施行された.腫瘍は横行結腸肝彎に存在し,肉眼的に腫瘍周囲は暗青色調の浮腫状粘膜を呈していた.病理組織学的にも腸間膜静脈硬化症に合致するもので,横行結腸癌に合併した腸間膜静脈硬化症と診断した. 腸間膜静脈硬化症は静脈硬化に伴う虚血性腸炎で,1991年に小山ら1)により初めて報告された.病理組織学的には腸間膜静脈の著明な線維性肥厚と石灰化,血管周囲への膠原線維の著明な沈着を特徴とする.稀な症例で現在のところ,アジアとりわけ日本からの報告例がある程度である.人種特異性が示唆されるが,成因や治療法,長期予後に関して良くわかっていない.癌の合併に関しては現状ではいわゆるcolitis cancerとは異なり,偶発的なものと考えられている.われわれの症例を含めて3例の癌の合併例が報告されている.成因,予後に関して明らかにするために,今後より多くの症例の蓄積,研究が待たれる. 悪性腫瘍を合併した腸間膜静脈硬化症の1例を経験したので若干の文献的考察を含めて報告する.

5 August 2024 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
AHAkio Higuchi
Akio Higuchi
YKYoshihiro Kubota
Yoshihiro Kubota
HYHajime Yokota
Hajime Yokota
HMHiroki Miyazaki
Hiroki Miyazaki
JOJoji Ota
Joji Ota
TUTakashi Uno
Takashi Uno